Brain natriuretic peptide as a predictor of cardiomyopathy in Chagas' disease [11]

Lancet

Volumn 361, Issue 9368, 2003, Pages 1567-

  Walther, Thomas ^a   Heringer Walther, Silvia ^a   Wessel, Niels ^b   Schultheiss, Heinz Peter ^a   V Moreira, Maria Da Consolação ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF POTSDAM   (Germany)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; MONOCLONAL ANTIBODY;

CARDIOMYOPATHY; CHAGAS DISEASE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CROSS REACTION; DISEASE MARKER; DISEASE SEVERITY; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; IMMUNORADIOMETRIC ASSAY; LETTER; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; ROC CURVE; SERODIAGNOSIS; SYSTOLIC BLOOD PRESSURE;

EID: 0037623257     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13209-6     Document Type: Letter

References (4)

1. Stein B.C., Levin R.I. Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am Heart J. 135:1998;914-923.
2. Ribeiro A., Reis A., Barros M., et al. Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease. Lancet. 360:2002;461-462.
3. Yasue H., Yoshimura M., Sumida H., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 90:1994;195-203.
4. McDonagh T.A., Robb S.D., Murdoch D.R., et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet. 351:1998;9-13.